Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diane M Da Silva

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
American Journal of Cancer (Auckland, N.Z.)|September 27, 2021
Vaccination Against Cervical Cancer: Hopes and RealitiesDiane M Da Silva, W Martin Kast
International Journal of Cancer|November 2, 2007
Recent advances in strategies for immunotherapy of human papillomavirus-induced lesionsShreya Kanodia, Diane M Da Silva, W Martin Kast
Cancer Research|July 4, 2003
Differential uptake and cross-presentation of human papillomavirus virus-like particles by dendritic cells and Langerhans cellsSteven C Fausch, Diane M Da Silva, W Martin Kast
Vaccine|June 14, 2003
Heterologous boosting increases immunogenicity of chimeric papillomavirus virus-like particle vaccinesDiane M Da Silva, John T Schiller, W Martin Kast
Vaccine|February 12, 2005
Heterologous papillomavirus virus-like particles and human papillomavirus virus-like particle immune complexes activate human Langerhans cellsSteven C Fausch, Diane M Da Silva, W Martin Kast
Cancers|September 9, 2022
Investigation of the Optimal Prime Boost Spacing Regimen for a Cancer Therapeutic Vaccine Targeting Human PapillomavirusDiane M Da Silva, Emma A Martinez, Lies Bogaert, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 29, 2014
Functional analysis of HPV-like particle-activated Langerhans cells in vitroLisa Yan, Andrew W Woodham, Diane M Da Silva, et al.
Cancer Immunity|April 25, 2008
Sperm fibrous sheath proteins: a potential new class of target antigens for use in human therapeutic cancer vaccinesMaurizio Chiriva-Internati, Everardo Cobos, Diane M Da Silva, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Human papillomavirus can escape immune recognition through Langerhans cell phosphoinositide 3-kinase activationSteven C Fausch, Laura M Fahey, Diane M Da Silva, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2002
Human papillomavirus virus-like particles do not activate Langerhans cells: a possible immune escape mechanism used by human papillomavirusesSteven C Fausch, Diane M Da Silva, Michael P Rudolf, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
American Journal of Cancer (Auckland, N.Z.)|September 27, 2021
Vaccination Against Cervical Cancer: Hopes and RealitiesDiane M Da Silva, W Martin Kast
International Journal of Cancer|November 2, 2007
Recent advances in strategies for immunotherapy of human papillomavirus-induced lesionsShreya Kanodia, Diane M Da Silva, W Martin Kast
Cancer Research|July 4, 2003
Differential uptake and cross-presentation of human papillomavirus virus-like particles by dendritic cells and Langerhans cellsSteven C Fausch, Diane M Da Silva, W Martin Kast
Vaccine|June 14, 2003
Heterologous boosting increases immunogenicity of chimeric papillomavirus virus-like particle vaccinesDiane M Da Silva, John T Schiller, W Martin Kast
Vaccine|February 12, 2005
Heterologous papillomavirus virus-like particles and human papillomavirus virus-like particle immune complexes activate human Langerhans cellsSteven C Fausch, Diane M Da Silva, W Martin Kast
Cancers|September 9, 2022
Investigation of the Optimal Prime Boost Spacing Regimen for a Cancer Therapeutic Vaccine Targeting Human PapillomavirusDiane M Da Silva, Emma A Martinez, Lies Bogaert, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 29, 2014
Functional analysis of HPV-like particle-activated Langerhans cells in vitroLisa Yan, Andrew W Woodham, Diane M Da Silva, et al.
Cancer Immunity|April 25, 2008
Sperm fibrous sheath proteins: a potential new class of target antigens for use in human therapeutic cancer vaccinesMaurizio Chiriva-Internati, Everardo Cobos, Diane M Da Silva, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Human papillomavirus can escape immune recognition through Langerhans cell phosphoinositide 3-kinase activationSteven C Fausch, Laura M Fahey, Diane M Da Silva, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2002
Human papillomavirus virus-like particles do not activate Langerhans cells: a possible immune escape mechanism used by human papillomavirusesSteven C Fausch, Diane M Da Silva, Michael P Rudolf, et al.
Pageof 7